Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Agnosia × Ketamine × Clear all

Phase

Phase 4 2 Phase 3 2 Phase 2/3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 4 Colorectal Neoplasms 3 Chronic Pain 3 Neoplasms 2 Breast Neoplasms 2 Pain 1 Neuralgia 1 Lymphoma, Follicular 1 Laparoscopic Colorectal Resection Due to Cancer 1 Hypoxia 1 Agnosia 1 Acute Pain 1

Interventions

Anesthesia, General 5 Dexmedetomidine 4 Bupivacaine 4 Anesthesia, Local 4 Acupuncture Therapy 4 parecoxib 2 Transcutaneous Electric Nerve Stimulation 2 Saline Solution 2 Ropivacaine 2 Radiofrequency Ablation 2 Pregabalin 2 Morphine 2 Fentanyl 2 Ethanol 2 Dental Occlusion 2 Control Groups 2 Anesthetics, Local 2 Anesthesia, Conduction 2 Analgesics, Opioid 2 loxoprofen 1 engage 8200 1 Yoga 1 Uterine Myomectomy 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Touch 1 Telemedicine 1 Surgical Instruments 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04597268 2023-01-10

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

National Cancer Institute, Egypt

Phase NA Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡